Ruxolitinib as a therapy choice for refractory pruritus in a patient with essential thrombocythemia with CALR mutation
<p>Refractory pruritus associated with Essential Thrombocythemia (ET) is rare. Herein, we present the first report of resistant pruritus responsive to ruxolitinib in an ET patient with a calreticulin mutation.</p>
Saved in:
Main Authors: | Kubra Cerci (Author), Pusem Patir (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Medical and Clinical Case Reports - Peertechz Publications,
2023-01-25.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lower Extremity Venous Ablation as a Treatment Modality for Refractory Lichen Simplex Chronicus and Generalized Pruritus
by: Robert Wills DO, et al.
Published: (2018) -
Porto-Splenic veins thrombosis and Budd-Chiari syndrome in a patient with essential thrombocythemia - is it always the myeloproliferative neoplasm to blame?
by: Suriu Celia, et al.
Published: (2021) -
Chapter 4 AVATAR Therapy for Refractory Auditory Hallucinations
by: Ward, Tom
Published: (2016) -
Chapter 4 AVATAR Therapy for Refractory Auditory Hallucinations
by: Ward, Tom
Published: (2016) -
Immune thrombocytopenic purpura with subsequent development of JAK2 V617F-positive essential thrombocythemia: Case Report
by: Marisabel Hurtado-Castillo, et al.
Published: (2021)